FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to use of a composition which contains at least a first active agent comprising amino acids leucine, isoleucine, valine, lysine, threonine, histidine, phenylalanine, methionine, tryptophan, tyrosine and cystine, in treating pain in patients suffering scheduled arthroplasty.
EFFECT: disclosed are compositions for treating pain in patients suffering scheduled arthroplasty.
15 cl, 2 dwg, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS CONTAINING AMINO ACIDS FOR APPLICATION WITHIN STROKE TREATMENT IN PATIENTS WITH DYSPHAGIA | 2015 |
|
RU2668373C1 |
| FODDER ADDITIVES REPRESENTED BY DIPEPTIDES | 2010 |
|
RU2536467C2 |
| FLAVOURING ADDITIVES | 2013 |
|
RU2639888C2 |
| USE OF AMINO ACID ADDITIVE FOR IMPROVED MUSCLE PROTEIN SYNTHESIS | 2018 |
|
RU2777605C2 |
| COMPOSITION AND METHODS FOR INCREASE OF NONFAT MUSCLE BULK AND/OR REDUCTION OF FAT GROWTH | 2006 |
|
RU2383209C2 |
| BIOLOGICALLY ACTIVE FOOD ADDITIVE | 2002 |
|
RU2222996C1 |
| MINERAL-AMINO ACID CONCENTRATE | 1994 |
|
RU2054879C1 |
| TREATMENT OF GENERAL DEVELOPMENT DISORDERS | 2007 |
|
RU2441652C2 |
| CONJUGATED IMMUNOGLOBULINS WITH C-TERMINAL LYSINE | 2016 |
|
RU2747581C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING INSULIN AND GLUCAGON | 2019 |
|
RU2823246C2 |
